Effect of prednisone and rituximab prephase on early toxicity in older DLBCL patients (pts) receiving RCHOP within a NHL specific comprehensive geriatric assessment (CGA) trial.

Authors

null

Colette Ngozi Owens

Memorial Sloan Kettering Cancer Center, New York, NY

Augustine Iannotta , John F. Gerecitano , Matthew J. Matasar , Ariela Noy , Craig H. Moskowitz , Pamela Drullinsky , Maria Lia Palomba , David J. Straus , Steven M. Horwitz , Andrew David Zelenetz , Carol S. Portlock , Anita Kumar , Paul A. Hamlin , Colette Ngozi Owens

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lymphoma and Plasma Cell Disorders

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Lymphoma

Clinical Trial Registration Number

NCT01829958

Citation

J Clin Oncol 33, 2015 (suppl; abstr 8571)

DOI

10.1200/jco.2015.33.15_suppl.8571

Abstract #

8571

Poster Bd #

389

Abstract Disclosures